Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tak Mak Insider Profile
4 Followers
Tak Mak, Director at CASI Pharmaceuticals, holds 545.45K shares in Agios Pharma (Ticker: AGIO), holds 365.38K shares in CASI Pharmaceuticals (Ticker: CASI). Most recently, Tak Mak Bought ― shares of Agios Pharma on Jul 23, 2013 for an estimated value of ―.
Tak Mak has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tak Mak holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tak Mak
Tak Mak's Trading History
CASI Pharmaceuticals
May 03, 2012
Director
Uninformative Buy
―
$2.00M
Agios Pharma
Jul 23, 2013
Ten Percent Owner
Informative Buy
―
$32.21M
List of latest transactions for each holding click on a transaction to see Tak Mak's performance on stock
You May Also Like
Tak Mak insider profile FAQ
What is the percentage of profitable transactions made by Tak Mak?
The percentage of profitable transactions made by Tak Mak is ―.
What is the average return per transaction made by Tak Mak?
The average return per transaction made by Tak Mak is ―.
What stocks does Tak Mak hold?
Tak Mak holds: CASI, AGIO stocks.
What was Tak Mak’s latest transaction?
Tak Mak latest transaction was an Informative Buy of ―.
What was Tak Mak's most profitable transaction?
Tak Mak’s most profitable transaction was an Informative Buy of AGIO stock on July 23, 2013. The return on the trade was 118.60%.
What is Tak Mak's role in CASI Pharmaceuticals?
Tak Mak's role in CASI Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.